29 studies found for:    Inclusion Body Myositis
Show Display Options
Rank Status Study
1 Enrolling by invitation Follistatin Gene Transfer to Patients With Becker Muscular Dystrophy and Sporadic Inclusion Body Myositis
Conditions: Becker Muscular Dystrophy;   Sporadic Inclusion Body Myositis
Intervention: Biological: rAAV1.CMV.huFollistatin344
2 Completed Arimoclomol in Sporadic Inclusion Body Myositis
Condition: Inclusion Body Myositis
Interventions: Drug: Arimoclomol;   Other: Placebo
3 Completed Efficacy, Safety and Tolerability of BYM338 in Patients With Sporadic Inclusion Body Myositis
Condition: Sporadic Inclusion Body Myositis
Interventions: Biological: BYM338;   Biological: Placebo
4 Completed Intravenousimmunoglobulin (IVIg) for the Treatment of Inflammatory Myopathies
Conditions: Dermatomyositis;   Inclusion Body Myositis;   Polymyositis
Intervention: Drug: Gamma Globulin
5 Completed Double-blind, Randomized, Placebo-controlled Trial of Etanercept for 12 Months in Subjects With Inclusion Body Myositis
Condition: Inclusion Body Myositis
Intervention: Drug: Etanercept
6 Completed Muscle Strength and Inflammatory Response in Patients With Inclusion Body Myositis
Condition: Inclusion Body Myositis
Intervention:
7 Completed Immune Abnormalities in Sporadic Inclusion Body Myositis
Conditions: Sporadic;   Inclusion Body;   Myositis
Intervention:
8 Completed Alemtuzumab to Treat Sporadic Inclusion Body Myositis
Condition: Myositis, Inclusion Body
Intervention: Drug: Alemtuzumab (Campath)
9 Recruiting Efficacy and Safety of Bimagrumab/BYM338 at 52 Weeks on Physical Function, Muscle Strength, Mobility in sIBM Patients
Condition: Sporadic Inclusion Body Myositis
Interventions: Drug: BYM338/bimagrumab;   Drug: Placebo
10 Completed Lithium in Inclusion Body Myositis (IBM)
Condition: Inclusion Body Myositis
Intervention:
11 Completed Anakinra in Myositis
Conditions: Polymyositis;   Dermatomyositis;   Inclusion Body Myositis
Intervention: Drug: Anakinra
12 Recruiting Adult and Juvenile Myositis
Conditions: Dermatomyositis;   Polymyositis;   Inclusion Body Myositis
Intervention:
13 Unknown  A Case-control Study to Assess Risk of Coronary Heart Disease in Idiopathic Inflammatory Myopathy
Condition: Idiopathic Inflammatory Myopathy
Intervention:
14 Recruiting Study and Treatment of Inflammatory Muscle Diseases
Conditions: Autoimmune Disease;   Dermatomyositis;   Inclusion Body Myositis;   Myositis;   Polymyositis
Intervention:
15 Completed Treatment With TNF Blockade, Infliximab, in Patients With Myositis
Condition: Refractory Myositis
Intervention: Drug: Infliximab
16 Completed Studies of the Natural History and Pathogenesis of Autoimmune/Connective Tissue Diseases
Conditions: Autoimmune/Connective Tissue Diseases;   Idiopathic Inflammatory Myopathies;   IIM
Intervention:
17 Recruiting Environmental Risk Factors for Myositis in Military Personnel
Conditions: Dermatomyositis;   Adult Polymyositis;   Inclusion Body Myositis;   Myositis
Intervention:
18 Recruiting Diagnostic Accuracy of Whole Body Magnetic Resonance Imaging in Inflammatory Myopathies
Conditions: Myositis;   Polymyositis;   Dermatomyositis;   Myositis, Inclusion Body
Intervention: Procedure: MRI-oriented muscle biopsy
19 Completed myoARRAY and TcLandscape Analysis for the Diagnosis of Inflammatory Myopathies
Conditions: Polymyositis;   Dermatomyositis
Interventions: Other: transcriptome analysis;   Other: T cell repertoire analysis
20 Completed Rituximab for the Treatment of Refractory Inflammatory Myopathies and Refractory Myasthenia Gravis
Conditions: Myositis;   Myasthenia Gravis
Intervention: Drug: Rituximab

Previous Page Studies Shown (1-20) Next Page (21-29) Show next page of results
Indicates status has not been verified in more than two years